Select Publications
Book Chapters
, 2024, 'WHAT ARE THE RISKS OF BIOLOGIC THERAPIES AND HOW DO YOU COMMUNICATE THEM TO PATIENTS?', in Curbside Consultation in Ibd 49 Clinical Questions, pp. 115 - 121, http://dx.doi.org/10.1201/9781003523567-23
Journal articles
, 2026, 'Gut Microbiota Are More Strongly Associated With Impairments in Health-Related Quality of Life Than Disease Activity in Inflammatory Bowel Disease', American Journal of Gastroenterology, 121, pp. 1929 - 1943, http://dx.doi.org/10.14309/ajg.0000000000003773
, 2026, 'The trend of obesity and inflammatory bowel disease in Australia and New Zealand: a bi-nation cohort study', Internal Medicine Journal, 56, pp. 1429 - 1432, http://dx.doi.org/10.1111/imj.70454
, 2026, 'It is time to examine the ‘HOW’ of care delivery as opposed to the ‘WHAT’', Internal Medicine Journal, 56, pp. 947 - 948, http://dx.doi.org/10.1111/imj.70495
, 2026, 'Functional validation of the TOpClass classification system for perianal fistulising Crohn’s disease using real-world multicentre data: a 10-year retrospective observational study', Frontline Gastroenterology, 17, pp. 212 - 221, http://dx.doi.org/10.1136/flgastro-2025-103198
, 2026, 'Diagnosis and Management of Upper Gastrointestinal Involvement in Adult Patients With Crohn’s Disease: A Systematic Review', Clinical Gastroenterology and Hepatology, 24, pp. 932 - 948, http://dx.doi.org/10.1016/j.cgh.2025.03.024
, 2026, 'Definitions, diagnosis, management, and outcomes of upper gastrointestinal Crohn's disease: an international, expert RAND/UCLA appropriateness study', Lancet Gastroenterology and Hepatology, 11, pp. 243 - 255, http://dx.doi.org/10.1016/S2468-1253(25)00347-4
, 2026, 'Low Rates of Surgical Recurrence Following Ileocolic Resections for Crohn’s Disease in the Biologic Era', Inflammatory Bowel Diseases, 32, pp. 421 - 432, http://dx.doi.org/10.1093/ibd/izaf244
, 2026, 'Global consensus statement on the management of pregnancy in inflammatory bowel disease', Gut, 75, pp. 208 - 251, http://dx.doi.org/10.1136/gutjnl-2025-336402
, 2026, 'Defining Radiological Healing in Perianal Fistulizing Crohn’s Disease: A TOpClass Global Expert Delphi Consensus', Clinical Gastroenterology and Hepatology, 24, pp. 190 - 200, http://dx.doi.org/10.1016/j.cgh.2025.02.009
, 2026, 'Dose-escalated biologic therapy improves outcomes in people with inflammatory bowel disease', Internal Medicine Journal, http://dx.doi.org/10.1111/imj.70562
, 2026, 'Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease', American Journal of Gastroenterology, 121, pp. 31 - 79, http://dx.doi.org/10.14309/ajg.0000000000003651
, 2026, 'Iron deficiency and anaemia in people with inflammatory bowel disease: do we have an ongoing issue of care quality? Crohns Colitis Cure data insights programme', Internal Medicine Journal, 56, pp. 38 - 42, http://dx.doi.org/10.1111/imj.70282
, 2026, 'P0452 A high Body Mass Index at baseline is not associated with certain poor IBD-related outcomes', Journal of Crohn’s and Colitis, 20, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.633
, 2026, 'Tissue penetration of anti-tumour necrosis factor therapy in perianal fistulising Crohn’s disease: a proof-of-concept study', European Journal of Gastroenterology and Hepatology, http://dx.doi.org/10.1097/MEG.0000000000003169
, 2026, '1058b GUSELKUMAB FOR PERIANAL FISTULIZING CROHN’S DISEASE: WEEK 24 RESULTS FROM THE PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER FUZION STUDY', Gastrointestinal Endoscopy, 103, pp. s - 2857, http://dx.doi.org/10.1016/s0016-5107(26)06685-x
, 2026, '1058b GUSELKUMAB FOR PERIANAL FISTULIZING CROHN’S DISEASE: WEEK 24 RESULTS FROM THE PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER FUZION STUDY', Gastroenterology, 170, pp. S - 2857, http://dx.doi.org/10.1016/s0016-5085(26)06754-5
, 2026, 'Mo1590 PRESCRIBING PATTERNS AND PERSISTENCE OF ADVANCED THERAPIES IN PEOPLE WITH ULCERATIVE COLITIS WHO ARE BIO-EXPERIENCED: CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM', Gastroenterology, 170, pp. s - 1201, http://dx.doi.org/10.1016/s0016-5085(26)03029-5
, 2026, 'Mo1590 PRESCRIBING PATTERNS AND PERSISTENCE OF ADVANCED THERAPIES IN PEOPLE WITH ULCERATIVE COLITIS WHO ARE BIO-EXPERIENCED: CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM', Gastrointestinal Endoscopy, 103, pp. s - 1201, http://dx.doi.org/10.1016/s0016-5107(26)02960-3
, 2026, 'Mo1597 PRESCRIBING PATTERNS AND PERSISTENCE OF ADVANCED THERAPIES IN PEOPLE WITH CROHN’S DISEASE WITH PRIOR ADVANCED THERAPY: CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM', Gastroenterology, 170, pp. s-1204-s-1205, http://dx.doi.org/10.1016/s0016-5085(26)03036-2
, 2026, 'Mo1597 PRESCRIBING PATTERNS AND PERSISTENCE OF ADVANCED THERAPIES IN PEOPLE WITH CROHN’S DISEASE WITH PRIOR ADVANCED THERAPY: CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM', Gastrointestinal Endoscopy, 103, pp. s-1204-s-1205, http://dx.doi.org/10.1016/s0016-5107(26)02967-6
, 2026, 'Mo1598 PRESCRIBING PATTERNS AND PERSISTENCE OF ADVANCED THERAPIES IN PEOPLE WITH CROHN’S DISEASE WITHOUT PRIOR ADVANCED THERAPY: CROHN’S COLITIS CARE DATA INSIGHTS PROGRAM', Gastroenterology, 170, pp. s - 1205, http://dx.doi.org/10.1016/s0016-5085(26)03037-4
, 2026, 'Mo1598 PRESCRIBING PATTERNS AND PERSISTENCE OF ADVANCED THERAPIES IN PEOPLE WITH CROHN’S DISEASE WITHOUT PRIOR ADVANCED THERAPY: CROHN’S COLITIS CARE DATA INSIGHTS PROGRAM', Gastrointestinal Endoscopy, 103, pp. s - 1205, http://dx.doi.org/10.1016/s0016-5107(26)02968-8
, 2026, 'Never‐Smoking Is Associated With Histologic Remission in Ulcerative Colitis: A Post‐Hoc Analysis of the VIEWS Randomised Controlled Trial', JCC Plus, 1, http://dx.doi.org/10.1002/jcc5.70051
, 2026, 'Patient reported outcomes are a practical tool for monitoring Crohn’s Disease activity in real world care.', Gastro Hep Advances, pp. 101104, http://dx.doi.org/10.1016/j.gastha.2026.101104
, 2026, 'Quality care outcomes in Inflammatory Bowel Disease: Doing more with less', Medical Research Archives, 14, http://dx.doi.org/10.18103/mra.v14i4.7288
, 2026, 'Sa1578 DIVIDED BY DISTANCE: INSIGHTS INTO REGIONAL DISPARITIES IN INFLAMMATORY BOWEL DISEASE CARE ACROSS AUSTRALIA FROM THE CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM', Gastroenterology, 170, pp. s - 992, http://dx.doi.org/10.1016/s0016-5085(26)02588-6
, 2026, 'Sa1578 DIVIDED BY DISTANCE: INSIGHTS INTO REGIONAL DISPARITIES IN INFLAMMATORY BOWEL DISEASE CARE ACROSS AUSTRALIA FROM THE CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM', Gastrointestinal Endoscopy, 103, pp. s - 992, http://dx.doi.org/10.1016/s0016-5107(26)02519-8
, 2026, 'Sa1584 SKIN CANCER SURVEILLANCE UPTAKE IN A REAL-WORLD AUSTRALASIAN INFLAMMATORY BOWEL DISEASE COHORT: CROHN’S COLITIS CURE (CCC) DATA INSIGHT’S PROGRAM', Gastroenterology, 170, http://dx.doi.org/10.1016/s0016-5085(26)02594-1
, 2026, 'Sa1584 SKIN CANCER SURVEILLANCE UPTAKE IN A REAL-WORLD AUSTRALASIAN INFLAMMATORY BOWEL DISEASE COHORT: CROHN’S COLITIS CURE (CCC) DATA INSIGHT’S PROGRAM', Gastrointestinal Endoscopy, 103, http://dx.doi.org/10.1016/s0016-5107(26)02525-3
, 2026, 'Su1539 AUTOMATED VERSUS CLINICIAN-ENTERED PHENOTYPING OF INFLAMMATORY BOWEL DISEASE USING AN AUSTRALASIAN MULTICENTRE REAL-WORLD DATABASE: CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM', Gastrointestinal Endoscopy, 103, pp. s-1062-s-1063, http://dx.doi.org/10.1016/s0016-5107(26)02677-5
, 2026, 'Su1539 AUTOMATED VERSUS CLINICIAN-ENTERED PHENOTYPING OF INFLAMMATORY BOWEL DISEASE USING AN AUSTRALASIAN MULTICENTRE REAL-WORLD DATABASE: CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM', Gastroenterology, 170, pp. s-1062-s-1063, http://dx.doi.org/10.1016/s0016-5085(26)02746-0
, 2026, 'Su1577 REAL-WORLD TRENDS IN SUBCUTANEOUS AND INTRAVENOUS INFLIXIMAB AND VEDOLIZUMAB USE IN INFLAMMATORY BOWEL DISEASE FROM 2021 TO 2024: INSIGHTS FROM CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM', Gastroenterology, 170, pp. s - 1081, http://dx.doi.org/10.1016/s0016-5085(26)02784-8
, 2026, 'Su1577 REAL-WORLD TRENDS IN SUBCUTANEOUS AND INTRAVENOUS INFLIXIMAB AND VEDOLIZUMAB USE IN INFLAMMATORY BOWEL DISEASE FROM 2021 TO 2024: INSIGHTS FROM CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM', Gastrointestinal Endoscopy, 103, pp. s - 1081, http://dx.doi.org/10.1016/s0016-5107(26)02715-x
, 2026, 'Su1579 TIMING AND PREDICTORS OF BOWEL RESECTION IN A LARGE CROHN’S DISEASE COHORT: INSIGHTS FROM THE CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM', Gastroenterology, 170, pp. s-1082-s-1083, http://dx.doi.org/10.1016/s0016-5085(26)02786-1
, 2026, 'Su1579 TIMING AND PREDICTORS OF BOWEL RESECTION IN A LARGE CROHN’S DISEASE COHORT: INSIGHTS FROM THE CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM', Gastrointestinal Endoscopy, 103, pp. s-1082-s-1083, http://dx.doi.org/10.1016/s0016-5107(26)02717-3
, 2026, 'Tu1628 COLECTOMY TRENDS IN ULCERATIVE COLITIS AMIDST AN EXPANDING THERAPEUTIC LANDSCAPE: INSIGHTS FROM A CLINICAL CARE REGISTRY', Gastroenterology, 170, pp. s-1334-s-1335, http://dx.doi.org/10.1016/s0016-5085(26)03315-9
, 2026, 'Tu1628 COLECTOMY TRENDS IN ULCERATIVE COLITIS AMIDST AN EXPANDING THERAPEUTIC LANDSCAPE: INSIGHTS FROM A CLINICAL CARE REGISTRY', Gastrointestinal Endoscopy, 103, pp. s-1334-s-1335, http://dx.doi.org/10.1016/s0016-5107(26)03246-3
, 2025, 'Australian Real-World Effectiveness and Safety of Ustekinumab for the Treatment of Crohn's Disease: Results of the AURORA Study, Including the ANZIBD Consortium', Jgh Open, 9, http://dx.doi.org/10.1002/jgh3.70322
, 2025, 'Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease', Alimentary Pharmacology and Therapeutics, 62, pp. 1125 - 1180, http://dx.doi.org/10.1111/apt.70290
, 2025, 'Patterns and Predictors of Steroid Use in a Real-World Inflammatory Bowel Disease Cohort', Jgh Open, 9, http://dx.doi.org/10.1002/jgh3.70308
, 2025, 'Top 10 research priorities in inflammatory bowel disease in Australia: findings using the James Lind Alliance approach', Internal Medicine Journal, 55, pp. 2083 - 2086, http://dx.doi.org/10.1111/imj.70201
, 2025, 'Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease', Clinical Gastroenterology and Hepatology, 23, pp. S1 - S60, http://dx.doi.org/10.1016/j.cgh.2025.04.005
, 2025, 'Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease', Inflammatory Bowel Diseases, 31, pp. 2615 - 2664, http://dx.doi.org/10.1093/ibd/izaf171
, 2025, 'Unravelling the Relationship between Obesity and Inflammatory Bowel Disease', Inflammatory Bowel Diseases, 31, pp. 2547 - 2560, http://dx.doi.org/10.1093/ibd/izaf098
, 2025, 'Crohn's Colitis Care, a Disease-Specific Electronic Medical Record, Enhances Data Capture in Pediatric Inflammatory Bowel Disease Care', Jgh Open, 9, http://dx.doi.org/10.1002/jgh3.70153
, 2025, 'Transcriptomic signatures of host immune responses in aphthous ulcers, the earliest lesions of Crohn's disease, suggest that bacterial uptake, rather than global dysbiosis, is the initiating factor', Immunology and Cell Biology, 103, pp. 473 - 484, http://dx.doi.org/10.1111/imcb.70031
, 2025, 'Proposal and exploration of a novel score to quantify patient-perceived burden of inflammatory bowel disease under routine care', Internal Medicine Journal, 55, pp. 589 - 598, http://dx.doi.org/10.1111/imj.16634
, 2025, 'Stomal calprotectin as a biomarker for assessing Crohn disease activity in patients with stomas', Internal Medicine Journal, 55, pp. 461 - 466, http://dx.doi.org/10.1111/imj.16648
, 2025, 'Active perianal fistulising Crohn's Disease is associated with a higher burden of psychological distress, depression, anxiety, stress and opioid use', JOURNAL OF CROHNS & COLITIS, 19, pp. I2311 - I2312, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1455